Recordati News and Activities

Presence

Recordati develops, manufactures, and markets medicines for specialty and primary care. Its products include treatments for rare diseases and common conditions, serving hospitals, healthcare professionals, and patients in international markets.

Recordati products and services overview:

Rare disease drugs
Specialty medicines
Primary care medicines
Urology treatments
Cardiovascular treatments
Consumer healthcare

Revenue: ~$3 billion

Employees: 4,500

Headquarters: Milan, Italy

Recordati is one of the...

Recordati is a company listed under the stock ticker REC (IT).

Recordati has a direct presence in 6 countries.

Recordati has 5 subsidiaries including Opalia Pharma, Recordati Benelux and Recordati Ireland & UK.

They are in:

Pharmaceuticals83%
Biotechnology17%

Acquisition, funding and merger involving Recordati.

CVC Capital Partners has announced the acquisition of Recordati (posted on May 26 2026).

Executives

View the org chart displaying its 81 main executives

Most searched biographies at Recordati

Popular executive movements at Recordati

Daniel Bastiaans, Vice President of Global Total Rewards, has left the company (posted on January 9 2026).
Attilio Benedetto, Head of Procurement Pharmaceutical Packaging Materials, has left the company (posted on November 6 2025).
Angela Tuozzi, who was Production Manager, is promoted to Production Director, Campoverde (posted on November 5 2025).

Click here to view some more movements at Recordati

Create your alert
to follow the executive moves at Recordati.